| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014487 |
| Receipt No. | R000016853 |
| Official scientific title of the study | Examination about the usefulness of the acetaminophen for intravenous injections after the operation of laparoscopic groin hernia restoration |
| Date of disclosure of the study information | 2014/07/07 |
| Last modified on | 2016/12/28 (Ver. 6) |
| Basic information | ||
| Official scientific title of the study | Examination about the usefulness of the acetaminophen for intravenous injections after the operation of laparoscopic groin hernia restoration | |
| Title of the study (Brief title) | Examination about the usefulness of the acetaminophen for intravenous injections after the operation of laparoscopic groin hernia restoration | |
| Region |
|
|
| Condition | ||
| Condition | groin hernia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | A pain occurs after the laparoscopic groin hernia restoration in a short term. NSAIDs or fentanyl continuous intravenous infusion is used to hang around for the sharp pain by facilities and an anesthesiologist, a surgeon.
This time, we attempt to study the usage of the acetaminophen for intravenous injections whether it was useful for painkilling after the laparoscopic groin hernia restoration and it could reduce perioperative opioid consumption. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Dosage of additional pain-killer |
| Key secondary outcomes | Pain level, time of pain-killer use, the number of the harmful phenomenon (shivering, nausea, vomiting) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Control group:Fentanyl sustained intravenous administration (0.3 micro gram/kg/h), given since 30 minutes before operation end.
|
|
| Interventions/Control_2 | Study group:Use the Intravenous acetaminophen since 30 minutes before operation end, and 3 times per 6 hour.Dosage is 15 mg/kg for the patient less than 50 kg in weight and 1000 mg for the patient more than 50 kg in weight. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | All patients who receive a target operation | |||
| Key exclusion criteria | A patient who always use a pain-killer, has a liver function disorder(AST or ALT>100), is obesity(BMI >=30), cannot understand the protocol. | |||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Michihisa Kato |
| Organization | Tokushima Red Cross Hospital |
| Division name | Anesthesiology |
| Address | Komatsushima Irinokuchi 103 |
| TEL | 0885-32-2555 |
| mmkato@tokushima-med.jrc.or.jp | |
| Public contact | |
| Name of contact person | Masanori Go |
| Organization | Tokushima Red Cross Hospital |
| Division name | Anesthesiology |
| Address | Komatsushima Irinokuchi 103 |
| TEL | 0885-32-2555 |
| Homepage URL | |
| mgo@tokushima-med.jrc.or.jp | |
| Sponsor | |
| Institute | Tokushima Red Cross Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016853 |